These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30037802)

  • 1. Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.
    Armenian SH; Yang D; Teh JB; Atencio LC; Gonzales A; Wong FL; Leisenring WM; Forman SJ; Nakamura R; Chow EJ
    Blood Adv; 2018 Jul; 2(14):1756-1764. PubMed ID: 30037802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.
    Armenian SH; Sun CL; Mills G; Teh JB; Francisco L; Durand JB; Wong FL; Forman SJ; Bhatia S
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1138-44. PubMed ID: 20197101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training.
    Scott JM; Armenian S; Giralt S; Moslehi J; Wang T; Jones LW
    Crit Rev Oncol Hematol; 2016 Feb; 98():222-34. PubMed ID: 26643524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.
    Leger KJ; Baker KS; Cushing-Haugen KL; Flowers MED; Leisenring WM; Martin PJ; Mendoza JA; Reding KW; Syrjala KL; Lee SJ; Chow EJ
    Cancer; 2018 Apr; 124(7):1507-1515. PubMed ID: 29315507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.
    Armenian SH; Sun CL; Vase T; Ness KK; Blum E; Francisco L; Venkataraman K; Samoa R; Wong FL; Forman SJ; Bhatia S
    Blood; 2012 Nov; 120(23):4505-12. PubMed ID: 23034279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant.
    Rhee JW; Pillai R; He T; Bosworth A; Chen S; Atencio L; Oganesyan A; Peng K; Guzman T; Lukas K; Sigala B; Iukuridze A; Lindenfeld L; Jamal F; Natarajan P; Goldsmith S; Krishnan A; Rosenzweig M; Wong FL; Forman SJ; Armenian S
    JAMA Cardiol; 2024 Jan; 9(1):16-24. PubMed ID: 37938837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation.
    Armenian SH; Ding Y; Mills G; Sun C; Venkataraman K; Wong FL; Neuhausen SL; Senitzer D; Wang S; Forman SJ; Bhatia S
    Br J Haematol; 2013 Oct; 163(2):205-13. PubMed ID: 23927520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual prediction of heart failure among childhood cancer survivors.
    Chow EJ; Chen Y; Kremer LC; Breslow NE; Hudson MM; Armstrong GT; Border WL; Feijen EA; Green DM; Meacham LR; Meeske KA; Mulrooney DA; Ness KK; Oeffinger KC; Sklar CA; Stovall M; van der Pal HJ; Weathers RE; Robison LL; Yasui Y
    J Clin Oncol; 2015 Feb; 33(5):394-402. PubMed ID: 25287823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease.
    Chang E; Iukuridze A; Echevarria M; Teh JB; Chanson D; Ky B; Chow EJ; Nakamura R; Lindenfeld L; Armenian SH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1233-1237. PubMed ID: 32171884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity.
    Ketterl TG; Chow EJ; Koves IH; Goodman P; Leisenring WM; Ballard S; Dengel DR; Moran A; Sinaiko AR; Steinberger J; Baker KS
    Transplant Cell Ther; 2024 Feb; 30(2):243.e1-243.e13. PubMed ID: 37935316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late congestive heart failure after hematopoietic cell transplantation.
    Armenian SH; Sun CL; Francisco L; Steinberger J; Kurian S; Wong FL; Sharp J; Sposto R; Forman SJ; Bhatia S
    J Clin Oncol; 2008 Dec; 26(34):5537-43. PubMed ID: 18809605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
    Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.
    de Vries S; Haaksma ML; Jóźwiak K; Schaapveld M; Hodgson DC; Lugtenburg PJ; Krol ADG; Petersen EJ; van Spronsen DJ; Ahmed S; Hauptmann M; Aleman BMP; van Leeuwen FE
    J Clin Oncol; 2023 Jan; 41(1):86-95. PubMed ID: 35947813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.
    Armenian SH; Sun CL; Shannon T; Mills G; Francisco L; Venkataraman K; Wong FL; Forman SJ; Bhatia S
    Blood; 2011 Dec; 118(23):6023-9. PubMed ID: 21976673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Cardiovascular Risk Factors and Individual Prediction of Cardiovascular Events in Childhood Cancer Survivors.
    Chen Y; Chow EJ; Oeffinger KC; Border WL; Leisenring WM; Meacham LR; Mulrooney DA; Sklar CA; Stovall M; Robison LL; Armstrong GT; Yasui Y
    J Natl Cancer Inst; 2020 Mar; 112(3):256-265. PubMed ID: 31161223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
    Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
    Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
    Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention.
    Armenian SH; Ryan TD; Khouri MG
    Heart Fail Clin; 2017 Apr; 13(2):337-345. PubMed ID: 28279419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.